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Epidermal growth factor (EGF) induces fibronectin (FN) and FN mRNA in rat liver epithelial cells, under conditions 
where the factor also induces the cells to migrate. Newly synthesized protein is secreted into the medium and deposited 
as substratum-bound extracellular matrix. The levels of mRNA and the amount of protein synthesized are not influenced 
by cyclic AMP or dexamethasone, factors that have been found to modulate FN expression in other cells. However, 
the cells are sensitive to the factors, suggesting acell-specific regulation. The EGF-induced RNA contains the sequences 
EIIIA and EIIIB characteristic of cellular fibronectin. 
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1. INTRODUCTION 
The dimeric, high A4, glycoprotein fibronectin 
(FN) is a component of normal plasma and of the 
extracellular matrix (ECM) of many cells, and 
fulfills essential functions in homeostasis, cell 
growth and differentiation [ 11. FN is also required 
for migration during development (e.g., neural 
crest cells [2]) and is involved in liver tissue repair 
[3] and liver cell migration [4]. From the single FN 
gene, up to 12 (rat [5]) or 20 (human [18]) variants 
can be derived by differential splicing of the 
primary transcript. The mRNA for plasma FN is 
devoid of the ED I (EIIIA) and ED II (EIIIB) se- 
quences, while cellular fibronectin contains both 
sequences, in variable combinations with a third 
domain of differential splicing [5,6]. It has also 
been shown that cells transformed with 
retroviruses carrying temperature-sensitive on- 
cogenes can modulate the splicing pattern with 
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changes in temperature [7). Overall, however, the 
mechanisms that determine the changes in the 
splicing pattern, and the role of the different pro- 
teins that result from it, remain to be determined. 
For some cell types it has been established that 
the amount of fibronectin they produce can be 
modulated by glucocorticoids [8], cyclic AMP 
[9, lo] and neoplastic transformation [ 11, but these 
data do not yet allow conclusions on the 
mechanisms that control the cell specific and 
developmentally regulated expression of the 
fibronectin gene. 
We have recently reported that rat liver 
epithelial cells induced to migrate by EGF deposit 
ECM migration tracks that contain FN as one of 
its components, and also synthesize increased 
amounts of the protein [4]. We now show that the 
induction of FN by EGF occurs shortly after ex- 
posure of the cells to the growth factor and is 
associated with an increase in the amount of 
mRNA for the cellular type of FN. The induction 
of FN in mouse fibroblastic cells released from 
serum starvation has been reported recently by 
others [ll]. 
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2. MATERIALS AND METHODS 
2.1. Cell culture and analysis of labeled proteins 
The cells were cultured in serum-free medium supplemented 
with insulin (2 pg/mI), insulin plus EGF (10 ng/ml) as previous- 
ly described [4], and in addition with dexamethasone (Sigma; 5 
x 10-s M) or cyclic AMP (dibutyryl cyclic AMP, Sigma; 5 x 
10e4 M). Labeling was achieved with 100 &i/ml 13.7 MBq/ml) 
of [3SS]methionine for 2 h [4], and as indicated in the figure 
legend. The labeled medium proteins were separated on 5 to 
15% polyacrylamide gels and analyzed by fluorography as 
previously described [4]. Substratum-bound ECM proteins were 
prepared as described [12], solubilized in sample buffer, 
separated on gradient gels and processed as the medium pro- 
teins. The 240 kDa band of these gels corresponds only to 
fibronectin, as previously determined by immunoprecipitation, 
immunoblotting and by 2D gel analysis. 
2.2. RNA extraction and hybridizations 
Total RNA was extracted by the standard guanidine isothio- 
cyanate method [13] with modifications [14]. Typically, 10 fig 
of RNA were obtained from 2 x lo5 cells. 20 fig of total RNA 
were separated on formaldehyde-containing gels, transferred to 
nitrocellulose membranes (Schleicher and Schuell) and 
hybridized [15] for 24 h at 43°C with probes pFH 154 [16] to 
detect otal FNmRNA, M 13EDl (ED1 domain [ 17)) or pFN 4H 
0.95 (ED 11 domain [18]), that had been nick-translated to a 
specific activity of 1.5 x 10’ dpm/pg. The concentration of 
labeled probes during the hybridization was 7.5 x lo5 dpm/ml. 
These cDNA probes of human FN are more than 80% 
homologous to rat FN DNA and share large segments of com- 
plete homology [16]. Filter blocking and hybridization was per- 
formed overnight at 43°C in rotating 50 ml cell culture 
polypropylene tubes (Falcon; Nunc), using 3 x SSPE, 50% for- 
mamide, 10% (w/v) PEG 6000,O. 1% SDS, 50 fig/ml denatured 
calf thymus DNA and 5OOrg/ml yeast tRNA. Posthybridiza- 
tion washes were performed in 1 x SSC, 50% formamide, 0.1% 
SDS at 43°C. 
3. RESULTS AND DISCUSSION 
The time course of synthesis of soluble fibronec- 
tin after addition of EGF to the cultures is shown 
in fig.1. The appearance of the newly synthesized 
protein in the medium is prevented by inhibitors of 
Asn-linked glycosylation (unpublished). The 
amount of newly synthesized FN deposited onto 
the substratum is also increased by EGF, as reveal- 
ed by radioactivity counting of the FN bands of 
fluorographed gels of labeled matrix preparations 
from two and four days after plating the cells. The 
amount of radioactive matrix fibronectin of 
cultures maintained in insulin plus EGF was in- 
creased 3- and 4.3-fold, respectively (2nd and 4th 
day), with respect o the cultures maintained in in- 
sulin alone. In agreement with previous results [4], 
no increase in cell number by EGF was observed in 
these cultures. It remains to be determined, if the 
insoluble FN of the matrix and migration tracks 
belongs to a different splicing variant than the pro- 
tein secreted into the medium. 
EGF also induces FN mRNA (fig.2). This RNA 
contains the EIIIA/EDI and EIIIB/EDII segments 
(fig.3) characteristic of the cellular type of 
fibronectin [5,6] indicating that most, if not all, 
FN RNA codes for the cellular form of the protein. 
The relative proportions of both domains of alter- 
native splicing however, have not been determined 
quantitatively, but the degree or kinetics of induc- 
tion of the message containing these domains is not 
significantly different (fig.3). 
The induction of FN messenger is suggested to 
result mostly from increased transcription, but a 
stabilization of the RNA cannot be excluded at the 
present time. However, in the few cases in which 
EGF has been identified unambiguously as an in- 
ducer of gene expression, the inducibility was 
found to be dependent on specific enhancer se- 
quences [19,20]. Similar sequences occur at - 260 
of the 5 ‘-region of the rat [22] and at - 268 of the 
human [lo] fibronectin genes. 
Earlier reports had indicated that glucocor- 
ticoids [8,21] and CAMP [9] can modulate the syn- 
thesis of the protein [8], or the formation of 
Fig.1. Time cdurse of fibronectin induction by EGF. Secreted fibronectin from cells labeled for 2 h, collected after addition of EGF 
at the times (h) indicated on each gel slot. Cultures supplemented only with insulin (In), and with insulin plus EGF (IE). 
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Fig.2. Time course of FN mRNA induction by EGF. RNA extracted from cultures after addition of EGF at the times (h) indicated 
on each gel slot, and hybridized with pFH 154 DNA to demonstrate the presence of FN mRNA. RNA from cultures supplemented 
only with insulin (In), and with insulin plus EGF (IE). 
immunohistologically detectable FN networks 
around cells [9,21]. The recent cloning of the 
5 ’ -genomic segments of the FN gene has revealed 
regulatory sequences for glucocorticoid- and 
CAMP-mediated regulation both in human and rat 
DNA [10,22]. With the cells of the present ex- 
periments, however, neither dexamethasone nor 
cyclic AMP modulate the induction of FN, either 
in the presence of insulin alone or in association 
with EGF (fig.4 and unpublished results). 
However, both factors have been found to effec- 
tively modulate the expression of several other 
genes in these cells (Bade and Feindler, in prepara- 
tion). Therefore, if the specific control sequences 
Fig.3. Sequences of alternative splicing in FN mRNA, 
demonstrated by hybridization with probes for EDI (I) and 
ED11 (II) sequences, respectively. Further details as for fig.2. 
have not been deleted or otherwise mutated, the 
lack of response is probably due to mechanisms 
that cell-specifically prevent a transcriptional ac- 
tivation of the FN gene. 
It has recently been reported /l l] that serum and 
EGF induce the expression of the fibronectin gene 
in fibroblastic mouse cells. In that study, however, 
the induced synthesis of the protein was associated 
directly with the growth response occurring after 
release from serum starvation. In contrast, with 
the epithelial cells of our experiments, the induc- 
tion of the protein is associated with the induction 
of migration, in the absence of a growth stimula- 
tion by the factor ([4] and above). In this context 
it is interesting to note that neither dexamethasone 
nor cyclic AMP affect the induction of migration 
by EGF (unpublished). 
The system is being further used for testing the 
interesting possibility that EGF might, in addition 
Fig.4. Fibronectin mRNA from cultures supplemented only 
with insulin (a), insulin plus EGF (b), insulin plus 
dexamethasone (c). insulin, EGF and dexamethasone (d), 
insulin plus CAMP (e), and insulin, EGF and CAMP (f), 
respectively, demonstrated by hybridization with pFH154. 
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to its (cell specific) regulation of the amount of FN 
produced by the cells, also modulate its splicing 
pattern in relation to the migratory behaviour it in- 
duces. These studies will require RNase protection 
assays that include the use of probes specific for 
the third domain (VAIICS) of differential splicing. 
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